Washington College of Law
     
Home Archive Volumes 50-59 Volume 51 Volume 51, Issue 5 COMMENT: The Rx-to-OTC Switch of Claritin, Allegra, and Zyrtec: An Unprecedented FDA Response to Petitioners and the Protection of Public Health
COMMENT: The Rx-to-OTC Switch of Claritin, Allegra, and Zyrtec: An Unprecedented FDA Response to Petitioners and the Protection of Public Health

By Holly M. Spencer

Click here to view this Comment